East Region Formulary
NHS Scotland

Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Esketamine
Spravato
Routinely available
SMC (SMC2258)
29/03/2023

Indication

In combination with a selective serotonin reuptake inhibitor (SSRI) or serotonin–norepinephrine reuptake inhibitor (SNRI), for adults with treatment-resistant major depressive disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe...

In combination with a selective serotonin reuptake inhibitor (SSRI) or serotonin–norepinephrine reuptake inhibitor (SNRI), for adults with treatment-resistant major depressive disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.

Therapeutic Area

Central nervous system

Status Description

Routinely available in line with national guidance

Formulation

28mg nasal spray, solution

Comments

-

Link to Advice

SMC2258

Advice Published

07/09/2020

SMC Submission Type

Full

SMC Status

Accepted